SCHEMBL28649145

SCHEMBL28649145

COC(=O)c1cccc(-n2cc(C3CC3)nc2S)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
GAA P10253 1/20 0.46
ALDH1A1 P00352 6/20 0.42
HPGD P15428 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.42
PDE4D Q08499 1/20 0.41
PTK2 Q05397 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
ESRRA P11474 1/20 0.39
PMM2 O15305 1/20 0.39
MPI P34949 1/20 0.39
RAB9A P51151 1/20 0.39
PHOSPHO1 Q8TCT1 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28643394 0.81 ALDH1A1 (0.41) ALDH1A1HPGDMAPTPDE4DSMN1; SMN2
SCHEMBL28657005 0.80 ALDH1A1 (0.41) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL28643803 0.79 MAP3K5 (0.53) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL21649342 0.69 TP53 (0.38) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL3933287 0.68 KMO (0.54) GAAALDH1A1HPGDMAPTPDE4D
SCHEMBL20672216 0.67 MAP3K5 (0.43) ALDH1A1SMN1; SMN2
SCHEMBL10145136 0.67 GAA (0.53) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL244928 0.67 ALDH1A1 (0.61) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL29641404 0.66 GAA (0.56) TP53GAAALDH1A1HPGDCYP1A2
SCHEMBL7830816 0.66 ALDH1A1 (0.54) TP53GAAALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109400625-B Fused bicyclic compound and application thereof in medicine 广东东阳光药业有限公司 2021-11-12 CN disclosed